SISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend

Bulletin Express

03/06

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復銳醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.

According to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1129289640"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129289640\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129289640?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 17:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129289640","market":"us","top_or_hot":-1,"title":"SISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend","media":"Bulletin Express","content":"<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復銳醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.</p>\n<p>According to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-06 17:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復銳醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.</p>\n<p>According to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01696","symbol_name":"复锐医疗科技","start_time":0,"source_url":"","article_id":"1129289640","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129289640","pubTimestamp":1772789065,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01696":"复锐医疗科技"},"translate_title":"SISRAM MED(01696)安排董事会会议讨论2025年年度业绩和股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01696":1},"content_text":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復銳醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.\nAccording to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}